NovoCure Ltd.
(NASDAQ : NVCR)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. 0.27%456.001.0%$740.33m
ABTAbbott Laboratories 0.82%117.300.8%$617.00m
DHRDanaher Corp. 0.70%252.020.7%$561.78m
MDTMedtronic Plc 1.00%124.350.6%$547.21m
ISRGIntuitive Surgical, Inc. 0.91%819.202.3%$501.40m
BSXBoston Scientific Corp. 0.97%41.751.0%$368.13m
BDXBecton, Dickinson & Co. 1.13%244.361.0%$359.61m
ALGNAlign Technology, Inc. 0.80%553.006.3%$319.91m
NVCRNovoCure Ltd. -0.49%178.956.8%$303.02m
DXCMDexCom, Inc. -0.55%331.647.8%$270.34m
SYKStryker Corp. 0.82%246.761.3%$264.58m
EWEdwards Lifesciences Corp. 0.63%88.020.4%$250.78m
AAgilent Technologies, Inc. 0.86%129.751.6%$203.25m
BAXBaxter International, Inc. 0.40%83.431.8%$197.58m
IDXXIDEXX Laboratories, Inc. 0.89%516.893.8%$186.76m

Company Profile

NovoCure Ltd. develops treatment for tumors. Its platform is called the Tumor Treating Field which used electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. The company was founded by Yoram Palti in 2000 and is headquartered in St. Helier, Jersey.